Blue Sail Medical Co.,Ltd. (SHE:002382)
China flag China · Delayed Price · Currency is CNY
5.41
0.00 (0.00%)
Oct 28, 2026, 9:45 AM CST

Blue Sail Medical Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
6,9425,6626,1774,8504,8348,064
Other Revenue
77.4777.4776.3776.7366.1844.59
7,0195,7406,2534,9274,9008,109
Revenue Growth
19.83%-8.21%26.91%0.54%-39.56%3.04%
Cost of Revenue
5,3004,9315,2624,3934,4814,382
Gross Profit
1,720808.29991.03533.82419.173,726
Selling, General & Admin
861.05814.78814.49788.43701.86765.15
Research & Development
260.64254.42341.92290.75352.49438.52
Other Operating Expenses
66.8743.2933.1827.5636.9254.78
Operating Expenses
1,1881,1201,2121,1251,0931,279
Operating Income
531.54-312.09-221.29-591.62-674.022,448
Interest Expense
-96.98-303.47-278.98-180.47-129.48-133.32
Interest & Investment Income
1441.5230.3840.67294.4481.06
Currency Exchange Gain (Loss)
30.0430.0453.0933.8862.8-86.36
Other Non Operating Income (Expenses)
-329.08-17.33-5.72-6.69-12.26-27.4
EBT Excluding Unusual Items
149.52-561.33-422.51-704.23-458.512,282
Impairment of Goodwill
------1,698
Gain (Loss) on Sale of Investments
-6.230.5-11.170.63-6.741,098
Gain (Loss) on Sale of Assets
-0.79-1.65-0.84-1.920.07-1.89
Asset Writedown
-134.83-157.91-6.29-21.47-6.94-370.68
Legal Settlements
17.2317.23----
Other Unusual Items
37.3742.0239.1434.3866.2638.08
Pretax Income
62.27-661.14-401.6-622.61-405.861,347
Income Tax Expense
298.08137.2863.32-54.25-33.54191.65
Earnings From Continuing Operations
-235.8-798.41-464.92-568.36-372.321,156
Minority Interest in Earnings
-94.439.4719.31-00
Net Income
-330.2-758.94-445.61-568.36-372.321,156
Net Income to Common
-330.2-758.94-445.61-568.36-372.321,156
Net Income Growth
------34.28%
Shares Outstanding (Basic)
9899991,0131,0151,0061,023
Shares Outstanding (Diluted)
9899991,0131,0151,0061,051
Shares Change
-2.14%-1.40%-0.21%0.86%-4.22%3.36%
EPS (Basic)
-0.33-0.76-0.44-0.56-0.371.13
EPS (Diluted)
-0.33-0.76-0.44-0.56-0.371.10
EPS Growth
------36.42%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
528.37-95.29-638.43-847.03-402.39-336.22
Free Cash Flow Per Share
0.53-0.10-0.63-0.83-0.40-0.32
Dividend Per Share
----0.400-
Dividend Growth
----0%-
Gross Margin
24.50%14.08%15.85%10.83%8.55%45.96%
Operating Margin
7.57%-5.44%-3.54%-12.01%-13.75%30.19%
Profit Margin
-4.70%-13.22%-7.13%-11.54%-7.60%14.25%
Free Cash Flow Margin
7.53%-1.66%-10.21%-17.19%-8.21%-4.15%
EBITDA
1,120243.3289.58-84.34-200.952,765
EBITDA Margin
15.96%4.24%4.63%-1.71%-4.10%34.10%
D&A For EBITDA
588.78555.39510.87507.27473.06317.51
EBIT
531.54-312.09-221.29-591.62-674.022,448
EBIT Margin
7.57%-5.44%-3.54%-12.01%-13.75%30.19%
Effective Tax Rate
478.67%----14.22%
Revenue as Reported
1,4815,7406,2534,9274,9008,109
Advertising Expenses
-84.6480.2988.3254.6124.98